aMoon is a leading Israeli life sciences venture fund. Our team is passionate about building successful businesses and helping Israeli biopharma, digital health and medical technology companies realize their potential.
Andreessen, Founders Fund Back Genomics Startup Exiting Stealth
Welcome to ’tissue therapeutics’: Dave Lennon’s $110M new venture will implant ‘happy cells’ that ‘survive and thrive’
Eleos Health raises $20 million to generate insights from mental health clinician-patient conversations
Nectin Therapeutics Announces $5.4 Million Investment from Cancer Focus Fund to Support Phase 1 Study of First-in-Class Anti-PVR Targeted Immunotherapy
Warburg Pincus Co-Leads Latest Funding Round in Israel’s MDClone
Precision immunology player bags $110M to fund its work on ‘disease signature’ tests
Omada Health Valued at $1 Billion-Plus in Fidelity-Led Round
Investors expect to pour more funds into digital health, survey shows
12 על 12: הדמויות המשפיעות בענף ההלת’טק
Adicet unveils early responses for off-the-shelf drug leveraging rare T cells. Will durability hold up?